The Drugs Controller General of India gave its greenlight to the Serum Institute of India, Pune for conducting Phase 2 and 3 human clinical trials for a vaccine candidate for the novel coronavirus disease (COVID-19) developed by the University of Oxford, London, reported news agency Press Trust of India.